联邦制药(03933.HK)：受托人透过市场交易购入350万股奖励股份

Core Viewpoint - The company, 联邦制药 (03933.HK), announced the purchase of 3.5 million reward shares at an average price of HKD 12.905 per share to fulfill its obligation to the beneficiaries who met the 2024 performance targets by November 13, 2025 [1] Group 1 - The trustee has acquired 3.5 million reward shares through market transactions [1] - The average purchase price for the shares was HKD 12.905 each [1] - The trustee will continue to purchase additional reward shares depending on market conditions until the shares are vested to the beneficiaries [1]